Company Information

Company Optima Pharmazeutische GmbH
www.optimapharma.de
Type:
SME
Country:
Germany
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
05 May 2014
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Communication On Progress

Published On Title Level/Status
17-Jun-2024 2024 Communication on Progress Submitted
16-Jun-2023 2023 Communication on Progress Submitted
05-May-2022 Optima Pharma Sustainability Report Active
07-May-2021 Optima - Sustainability Report 2021 Active
08-May-2020 Optima - Sustainability Report 2020 Active
08-May-2019 Optima - Sustainability Report 2019 Active
08-May-2018 Optima - Sustainability Report 2018 Active
08-May-2017 Optima - Sustainability Report 2017 Active
06-May-2016 Sustainability Report 2015 / UNGC COP Active
05-May-2015 Sustainability Report 2015 / UNGC COP Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note: We can redact your name, signature and any other personal information from your CoP. However, in alignment with our standard procedure, please note that we do not delete the online profile of a former participant, nor its letters of commitment and/or any other documents (including CoPs) that have been submitted voluntarily by participants as part of their engagement with our initiative. Transparency and disclosure are core values to which participants adhere when joining the UN Global Compact, and we continue to uphold these values by ensuring a transparent record of our current and past participants on our public database. Please see our CoP Removal Request Policy for more information.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.